C*VID-19 Jab M*nufacturer To Pay *ver $1 B*llion In V*ccine R*yalties In S*parate S*ttlement *greements

German company BioNTech, who partnered with Pharma giant Pfizer to manufacturer an mRNA COVID-19 jab, has entered into separate settlement agreements over the payment of royalties related to its experimental shot.

The biotechnology company will pay $791.5 million to the U.S. National Institutes of Health (NIH).

In a separate agreement,